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Comprehensive Neuropsychological Assessment of Cognitive 1 
Functioning of Adults with Lower Limb Amputation in Rehabilitation 2 
 3 
Objective: To establish a comprehensive profile of cognitive functioning in people engaged 4 
in lower limb amputation (LLA) rehabilitation.  5 
Design: Cross-sectional study as part of a longitudinal pros ective cohort. 6 
Setting: A national, tertiary, rehabilitation hospital. 7 
Participants: Adult volunteer participants (N=87) referred for comprehensive rehabilitation 8 
for major LLA were sampled from 207 consecutive admissions. Participants with both 9 
vascular (n=69) and non-vascular (n=18) LLA aetiologies were included. 10 
Interventions: Not applicable 11 
Main Outcome Measure(s): Demographic and health information, and a battery of 12 
standardised neuropsychological assessments  13 
Results: Compared to normative data, impairment was evident in overall cognitive 14 
functioning (p≤.003). Impairment was also evident in particular areas, including reasoning, 15 
psychomotor function, information processing, attention, memory, language/naming, 16 
visuospatial functions, and executive functions (all p≤.003 Holm-corrected). There were also 17 
higher frequencies of impaired functions across most aspects of functioning in this group, 18 
compared to expected frequencies in normative data (p≤.003 Holm-corrected). There were no 19 
significant differences in cognitive functioning betw en participants of vascular and non-20 
vascular LLA aetiology.  21 
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Conclusions: Findings support the need for cognitive screening at rehabilitation admission 22 
regardless of aetiology. Administration of comprehensive neuropsychological assessment 23 
with a battery sensitive to vascular cognitive impairment is recommended in some cases, to 24 
generate an accurate and precise understanding of relative strengths and weaknesses in 25 
cognitive functioning. Cognitive functioning is a potential intervention point for 26 
improvement of rehabilitation outcomes for those with LLA and further research is warranted 27 
in this area. 28 
Key Words: Amputation; cognition; lower extremity; neuropsychology; rehabilitation 29 
research  30 
  31 
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List of abbreviations 32 
• BADS: Behavioural Assessment of the Dysexecutive Syndrome 33 
• CVLT-II SF: California Verbal Learning Test II Short Form 34 
• D-KEFS: Delis Kaplan Executive Function System 35 
• FrSBe: Frontal Systems Behavior Scale – self-rated 36 
• LLA: lower limb amputation  37 
• MCI: mild cognitive impairment 38 
• MoCA: Montreal Cognitive Assessment 39 
• PVD: peripheral vascular disease 40 
• RBANS: Repeatable Battery for the Assessment of Neuropsychological Status 41 
• TEA: Test of Everyday Attention  42 
• VCI: vascular cognitive impairment 43 
• VOSP: Visual Object and Spatial Perception Battery 44 
• WAIS-IV: Wechsler Adult Intelligence Scales-IV 45 
• WMS-IV: Wechsler Memory Scale-IV   46 
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In economically developed countries, most major lower limb amputations (LLA) result from 47 
dysvascularity, i.e. peripheral vascular disease (PVD) and diabetes mellitus 1. People with 48 
LLA (PwLLA) are at greater risk of having or developing impaired cognitive functioning 2,49 
with high prevalence of dysvascularity as a precipitating factor in LLA likely underlying this 50 
risk. PVD is a marker for generalised cardiovascular and cerebrovascular pathology, and has 51 
been linked to impaired cognitive functioning and vascular cognitive impairment (VCI) 3–5. 52 
Overall cognitive functioning, processing speed, attention, immediate and delayed memory, 53 
naming, visuospatial construction, and executive functions are impaired in VCI 6. Diabetes 54 
has been associated with a similar profile of impairment7. Furthermore, the increasing age at 55 
which most LLA are carried out itself presents increasing risk of cognitive impairment and 56 
dementia 8. In essence, LLA risk factors – dysvascularity anddvanced age – are shared risk 57 
factors for cognitive impairment. Impaired cognitive functioning may explain a proportion of 58 
the variance in rehabilitation outcomes 9; yet relatively little research has considered 59 
cognitive functioning in PwLLA 2. While there is some evidence of impaired memory 10, 60 
information processing 11, and executive functioning deficits 10,11 in PwLLA, a 61 
comprehensive understanding has been hampered by limitations of methodology and scope of 62 
the extant research literature.  63 
Profiles of cognitive functioning are heterogeneous; people have variable relative 64 
strengths and weaknesses across different aspects of functioning, the degree of such strengths 65 
and weaknesses also varies. Most previous research however has relied on simple categorical 66 
definitions of cognitive functioning (e.g. 12–16), including unspecified dementia diagnoses, 67 
rather than standardised neuropsychological assessment. This approach neglects the range of 68 
functioning in the LLA population, ultimately limiting understanding of the range of potential 69 
contributors to rehabilitation outcomes. Furthermore, studies examining cognitive profiles 70 
have generally used cognitive screens or narrow assessment batteries, which do not capture 71 
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the breadth of functioning or are insensitive to VCI 10,17,18. In some cases, reporting was not 72 
sufficient to make determinations regarding the profile 12,18. Drawing conclusions from other 73 
studies is limited by sample sizes  or  research designs that preclude generalisation 11,19. 74 
Comparisons between patients of vascular and non-vascular LLA aetiology are also lacking, 75 
limiting our understanding of the general profile of functioning in the LLA rehabilitation 76 
population.  77 
Recent work with a large sample with LLA (N=1086) examined self-reported 78 
cognitive concerns (i.e. difficulties in functioning) 20. Respondents reported significantly 79 
more cognitive concerns than a general population normative sample, regardless of age or 80 
aetiology. However, self-report and third party observation may not be reliable indicators of 81 
cognitive functioning. Persons with executive functioning difficulties may lack insight into 82 
their own cognitive functioning and behaviour. Additionally, difficulties with aspects of 83 
cognitive functioning can be masked, for example by intact language production skills. With 84 
greater scope than cognitive screens, comprehensive europsychological assessment can 85 
elucidate the breadth and depth of cognitive strenghs and weaknesses, thus assisting 86 
treatment or rehabilitation planning21. 87 
The purpose of this study was to generate a comprehensive neuropsychological 88 
profile of people who attended rehabilitation at a national rehabilitation hospital following 89 
LLA. The aim was to describe cognitive functioning  terms of a) whether LLA 90 
rehabilitation participants’ assessment scores differed from normative means, and b) the 91 
proportions of the sample with scores in the borderlin  or impaired ranges of functioning. 92 
Cognitive functions assessed included overall cognitive functioning, reasoning, psychomotor 93 
speed, information processing, attention, memory, visuospatial perception and construction, 94 
language, and executive function, as well as estimated premorbid intellectual ability. A 95 
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secondary aim was to investigate differences between participants with vascular and non-96 
vascular aetiologies.  97 
 98 
 99 
Methods 100 
 101 
Design 102 
This cross-sectional study forms part of a longitudinal prospective cohort study investigating 103 
cognitive functioning and rehabilitation outcomes in PwLLA enrolled in a comprehensive 104 
LLA rehabilitation programme at a Commission for Accreditation of Rehabilitation Facilities 105 
(CARF) -accredited rehabilitation hospital.  106 
 107 
Participants 108 
Inclusion criteria were: presence of a major LLA (i.e. unilateral or bilateral from ankle to hip 109 
level), English language fluency, age≥18 years. Exclusion criteria were: major upper limb 110 
amputation (i.e. wrist disarticulation or above; participants with transphalangeal or partial 111 
hand amputation were not excluded provided they could manipulate assessment materials), or 112 
being too medically unwell.  113 
Eighty-seven participants were recruited. Of 207 consecutive admissions over two 114 
years, 3 were excluded as medically unwell, 1 was non-English speaking, and 116 declined. 115 
Participants gave written, informed consent prior to participation. The hospital’s Ethics 116 
Committee approved this research.  117 
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 118 
Measures 119 
Demographic and clinical data were collected from healthcare records. Distress was assessed 120 
using Hospital Anxiety and Depression Scale total scores 22,23. The battery of standardised 121 
neuropsychological assessments was selected to provide a comprehensive profile of cognitive 122 
functioning and impairment, be sensitive to VCI, and limit burden on participants. It and 123 
aspects of cognitive functioning examined are noted in table 2. Higher scores indicate higher 124 
levels of functioning, with exception of the Frontal Systems Behaviour Rating Scale (FrSBe), 125 
for which lower scores indicate better self-rated functioning. All measures were age 126 
standardised, with the FrSBe also gender normed.  127 
 128 
Procedure 129 
The majority of participants engaged in at least two assessment sessions, lasting on average 130 
50 minutes. Where timetables allowed, sessions up to a prox. 110 minutes with a short break 131 
in the middle were conducted. Sessions continued until the battery (approx. 3.5 hours) was 132 
completed, or discontinued due to participants declining further participation, limitations on 133 
timetable availability, or early discharge from rehabilitation. Assessments were undertaken 134 
while participants were engaged in a busy rehabilittion programme, and were delivered 135 
across sessions in an order that minimised the risk of assessments interfering with each other. 136 
As completion rates differed, the order of test administration was altered to prioritise 137 
completion of measures of overall cognitive functioning in the first instance (e.g. RBANS), 138 
then measures tapping into each of one of the following domains: attention, memory, 139 
executive function, and then the remainder of the battery. Some assessments were completed 140 
as part of routine clinical assessment. Participants were referred to a senior clinical 141 
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neuropsychologist (FOK) if they requested feedback on assessments or in instances of 142 
distress.  143 
 144 
Analysis 145 
To examine relationships between demographic and cli ica  variables and 146 
neuropsychological assessments, including whether score  differed between vascular and 147 
nonvascular amputation aetiologies, independent samples t-tests, Mann-Whitney U tests, and 148 
Spearman rho correlations were used. In assessing whether LLA rehabilitation participants' 149 
assessment scores differed from normative means, one-sample t-tests were used. Sample 150 
means were compared against the means and standard deviations of published normative 151 
values for each assessment. Similar analyses have been used previously20,24, and allow for an 152 
inferential estimation of whether and how cognitive functioning in (this whole sample of) 153 
PwLLA differs from the general population.  154 
 To estimate the proportions of PwLLA in rehabilitation programmes that might 155 
require particular rehabilitative attention due to difficulties with various aspects of cognitive 156 
functioning, separate chi-square analyses investigated with the distribution of scores at each 157 
of three levels (where normative values were available). The levels were impaired (z≤-2.0; 158 
scale scores 1-3; ≤2nd percentile), borderline (-1.99≤z≤-1.5; scale scores 4-5; ≤7th percentile 159 
approx.) and not impaired. This classification of ‘impairment’ is used in the Wechsler 160 
classification system25; the z=-1.5 borderline classification has been used in studies of mild 161 
cognitive impairment (MCI) 26–28. Two assessments were exceptions: FrSBe 29 (borderline: 162 
60≥T ≤64; impaired: T≥65) and VOSP Position Discrimination (borderline: raw score 18/20; 163 
impaired: raw score ≤17/20).   164 
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Holm’s method of correction for multiple comparison 30,31 was employed on a 165 
family-wise basis. Effect sizes reported are Cohen’s d (small≥.2, medium≥.5, large≥.8). Data 166 
were analysed with IBM SPSS Statistics version 21.  167 
 168 
Results  169 
Sample demographic and clinical characteristics are summarised in Table 1. Participants with 170 
dysvascular LLA (PVD or diabetes) were significantly o der (n=69, M=62.93, SD=12.02, 171 
range=33–86) than the non-vascular group (n=18, M=41.89, SD=15.13, range=21–73) 172 
(t(85)=6.26, p<.001). Groups did not differ in education, gender, marital status, amputation 173 
level, number of comorbidities, distress, or length of stay. The sample was slightly younger 174 
than the group of all potential participants attending LLA rehabilitation at the recruitment site 175 
(annual M=60 to 63 during recruitment years). Other demographic or clinical information of 176 
non-participants was not available.  177 
 178 
 179 
========== 180 
INSERT TABLE 1 ABOUT HERE 181 
========== 182 
 183 
Cognitive functioning was impaired, both generally nd across specific domains, as 184 
evident in the significantly lower performance of the sample on the clear majority of aspects 185 
of cognitive functioning assessed relative to normative means. Results of this main analysis 186 
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are summarized in table 2, which also provides information on normative means and standard 187 
deviations for reference. This sample did not differ rom the normative population in 188 
estimated premorbid intellectual ability. Overall cognitive functioning was significantly 189 
lower (RBANS Total Index; d=-.9), and the mean MoCA score of 22.9 (SD=3.99) was below 190 
the cut-off (<24 32) for suspected cognitive impairment. The sample scored significantly 191 
lower on all three reasoning assessments (d≤-.52) and on psychomotor speed (d=-.72). For 192 
information processing, significantly lower scores were evident on colour-naming (D-KEFS 193 
Color-Word Interference Condition 1(Colour Naming), d=-.7), and difficult, time-pressured 194 
tasks (RBANS Coding, d=-1.25; WAIS-IV Symbol Search, d=-1.03), but not word reading 195 
(D-KEFS Color-Word Interference Condition 2 (Word Reading), d=-.29). All assessments of 196 
focused and sustained attention were significantly lower (-.69≥d≥-1.45), but differences in 197 
attention span and divided attention were non-significant (RBANS Digit Span, d=.12; TEA 198 
Telephone Search While Counting, d=-.22). Both immediate list learning scores were 199 
significantly lower (-.42≥d≥-.8). The sample fared better on immediate story memory, with a 200 
non-significant difference on a shorter story (RBANS Immediate Story Memory, d=-.24), and 201 
a significant difference of small effect size for lnger stories (WMS-IV Logical Memory I, 202 
d=-.47). There was no significant difference in recall after a 1 minute delay following four 203 
trials of a verbal list (CVLT-II SF short delay free recall, d=-.3). All aspects of recall after 204 
longer delays (circa 20+ minutes), were significantly lower (-.44≥d≥-.73). Delayed 205 
recognition scores were also significantly lower (RBANS List Recognition, d=-.58), even 206 
when cues were provided (CVLT-II SF cued recall, d=-.84). No difference was evident in 207 
confrontational naming of everyday objects (RBANS Naming, d=-.23). The GNT included 208 
less common items, and the mean raw score (16.95, SD=6.44) corresponded to approximately 209 
the 25th percentile. Participants fared better on visuospatial perception (VOSP Position 210 
Discrimination M=18.98, SD=1.61, within the ‘pass’ range; RBANS Line Orientation, d=-211 
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.17) than construction (RBANS Figure Copy, d=-.54). Of the core aspects of executive 212 
functioning, significantly lower scores were evident in inhibition (D-KEFS Color-Word 213 
Interference Condition 3 (Color-Word Switching), d=-.76), cognitive flexibility (D-KEFS Trail 214 
Making Test Condition 5 (Number-Letter Switching), d=-1.05), and all aspects of verbal fluency (-215 
.42≥d≥-.72). Working memory, which did not differ, was an exception (WAIS-IV Digit Span, d=-.15, 216 
ns). The planning (BADS Zoo Map) mean score corresponded to borderline impaired functioning. 217 
Self-rated executive and frontal lobe dysfunction (including apathy, behavioural disinhibition, 218 
dysexecutive functioning) was significantly higher (F SBe Self-Rated Total, d=.59).  219 
 220 
========== 221 
INSERT TABLE 2 ABOUT HERE 222 
========== 223 
 224 
 Significantly higher proportions of the sample had borderline and impaired scores 225 
compared to normative populations across the cognitive functioning spectrum (see table 3). 226 
This included overall cognitive functioning (RBANS Total Index, 34% of scores), visual 227 
abstract reasoning (WAIS-IV Matrix Reasoning, 21%), psychomotor speed (D-KEFS Trail 228 
Making Test Condition 5 (motor speed), 19%), and complex, time pressured information 229 
processing (RBANS Coding, 58%; WAIS-IV Symbol Search 33%). This was also the case 230 
for all aspects of attention (range=11-41%) except divided attention, all aspects of immediate 231 
and delayed memory (range=21-41%), confrontational naming (RBANS Naming, 17%), 232 
visuospatial perception (line orientation, 22%), and construction (figure copy, 43%). Similar 233 
results were found for a range of executive functions including inhibition (38%), cognitive 234 
flexibility (47%), and verbal fluency (category and phonemic, 19-23%). Additionally, a 235 
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significantly higher proportion had scores in the borderline or extremely low range for 236 
estimated premorbid intellectual functioning (WTAR, 22%). 52.6% of MoCA scores fell at or 237 
below the selected cut off (<24). The VOSP Position Discrimination task was failed by 28% 238 
of those who completed the measure. For planning (BADS Zoo Map), 88% of scores were in 239 
the borderline or impaired ranges. FrSBe self-ratings were above the threshold for executive 240 
and frontal lobe dysfunction (including apathy and behavioural disinhibition) for 45.5% of 241 
those who completed the measure.  242 
 243 
========== 244 
INSERT TABLE 3 ABOUT HERE 245 
========== 246 
 247 
Mann-Whitney U tests indicated no significant differences in assessment scores 248 
between aetiology groups (scores for the vascular and non-vascular groups are provided in 249 
table 3 for comparative purposes, with additional iformation in table S1 [online 250 
supplement]). Amputation level, length of stay, marital status, and distress (HADS) were 251 
unrelated to test scores. Older age was significantly related to lower MoCA (rs=-.503, 252 
p<.001) and lower RBANS Line Orientation (visuospatial perception, rs=-.443, p<.001) 253 
scores. More comorbidities (dichotomised as two or fewer versus three or more) related to 254 
lower RBANS Coding scores (information processing, t(71)=3.576, p=.001). There were no 255 
differences in assessment scores (or a range of demographic and clinical variables) between a 256 
group which completed ≥90% (n=25) of the assessments and those who completed <90% (n 257 
= 62), with one exception: RBANS Immediate Story Memory (t(65.236)=-3.439, p=.043).  258 
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 259 
   260 
 261 
 262 
 263 
Discussion 264 
This study was the first to employ such a broad battery of standardised neuropsychological 265 
assessments, selected purposefully to be sensitive to common features of VCI, to provide a 266 
profile of cognitive functioning in admissions to rehabilitation programmes. The profile is 267 
one of high degree and prevalence of impairment in overall cognitive functioning as well as 268 
widespread impairment across domains, including reasoning, information processing, 269 
attention, immediate memory/learning, delayed recall and recognition memory, naming less 270 
commonplace objects, visuospatial perception and costruction, and executive functions 271 
including cognitive flexibility/set-shifting, inhibtion, verbal fluency, and planning. Particular 272 
difficulties, in both magnitude and prevalence of difficulty, were evident in overall cognitive 273 
functioning; processing  speed(especially under time pressure); focusing attention and 274 
sustaining concentration; learning verbal information, and; recalling newly learned 275 
information even with cuing. Among executive functions, cognitive flexibility (switching 276 
between tasks and thinking creatively), and planning presented particular difficulties. 277 
The results support research suggesting increased overall susceptibility to cognitive 278 
impairment 2, impaired processing speed and executive functioning 11 and reduced immediate 279 
and delayed list recall and verbal fluency across time in dysvascular LLA 10, and similar 280 
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findings in PVD 3. Importantly, this study evidences impairment across a much wider range 281 
of cognitive domains.  282 
In economically developed countries, persons with dysvascular LLA predominate in 283 
LLA rehabilitation programmes. Impairment observed in these individuals is likely linked to 284 
cerebrovascular diseases. The observed profile was largely consistent with VCI; difficulties 285 
with overall cognitive functioning with particularly high frequency of impairments of 286 
processing speed, executive functioning, attention, and memory. Yet, LLA aetiology does not 287 
map reliably onto impairment status. The similarly poor performance of non-vascular LLA 288 
participants across the full range of assessments raises questions about cognitive functioning 289 
in this group. Previous research on found that people with traumatic LLA were no less 290 
concerned about their cognitive functioning than those with vascular LLA 20, though how 291 
subjective concerns map onto and objective assessment  of cognitive functioning is uncertain. 292 
Demographic or clinical factors, including distress, did not explain the lack of difference 293 
between aetiologies. One possible explanation is the presence of vascular risk factors; a third 294 
of the non-vascular group had cardiovascular comorbidities. Additional risk of traumatic 295 
amputation in dysvascularity has been reported previously 33 (vascular insufficiency likely 296 
being a contributory factor).  297 
Half of participants scored below the selected cut-off for cognitive impairment 298 
(MoCA <24), suggesting that comprehensive neuropsychological assessment may be 299 
appropriate for at least half of LLA rehabilitation programme admissions. Cut-off sensitivity 300 
and specificity 32 suggest that approximately a quarter of participants could meet MCI 301 
criteria. A reliable and valid cognitive screen, sen itive to VCI, should be administered on 302 
admission to LLA rehabilitation, even to those with non-vascular LLA aetiology. Individuals’ 303 
patterns of strengths and impairments varied with complexity which could not have been 304 
captured with categorical measures alone (e.g. screening pass/fail). More accurate and precise 305 
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understandings of patients’ relative or actual strengths and weaknesses are possible by 306 
twinning cognitive screening as standard with comprehensive neuropsychological assessment 307 
as required. A non-exhaustive list of instances suggesting benefit in neuropsychological 308 
assessment includes: scoring below or near a cognitive screen cut off; notable discrepancies 309 
between scores in different domains on a cognitive scr en; functional difficulties suggestive 310 
of cognitive difficulties; and self-reported or other-reported cognitive difficulties.  311 
While there are clear resource implications for implementing neuropsychological 312 
assessment, potential benefits include earlier and better understanding of why difficulties may 313 
arise with particular tasks, functioning, or activities of daily living 34,35, prosthesis use or 314 
mobility 36–39, self-management and compliance with medical regimn 40,41, or social 315 
integration and community participation 39. Additionally, declines in cognitive functioning 316 
may have implications for sustaining achieved goals in the longer term. Prospective 317 
associations between cognitive functioning and rehabilit tion outcomes suggest an influence 318 
on longer-term outcomes 36,39. Timely assessment would improve potential for earli r 319 
intervention to mitigate these difficulties with concomitant benefits of reduced healthcare 320 
expenditure and resource use.  321 
Research is required to examine whether lower premobid cognitive functioning or 322 
intellectual ability confer additional amputation risk. While mean estimated premorbid 323 
intellectual ability did not differ from normative values, a greater proportion of this sample 324 
was in the borderline and extremely low ranges. Self-management of later-stage PVD carries 325 
a cognitive burden and requires motivation. Brief cognitive screening for at-risk persons 326 
could contribute to LLA prevention.  327 
This study evidences impairment across attention, memory, and executive functions 328 
which could reasonably be considered particularly important for rehabilitation and outcomes. 329 
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Intact cognitive functioning is likely to be important in learning to effectively and safely don, 330 
doff, transfer and ambulate with, and maintain prosthe es, but LLA rehabilitation now 331 
extends beyond prosthetic provision and training 9,42 . Some people achieve functional 332 
independence and adjust well after LLA, yet others do not 9. Reintegration into community 333 
living and social roles may depend somewhat on cognitive functions and their successful 334 
application. Some additional cognitive burdens for PwLLA include planning, activity 335 
organization, and memory for prosthetic procedures. Understanding precipitant factors of 336 
good and poor activity performance, participation, a d overall adjustment to limb loss will 337 
assist in rehabilitation programme development and optimization. Cognitive rehabilitation 338 
has already yielded promising results in facilitating prosthesis use 19 and its efficacy in 339 
improving other outcomes should be researched. Clinicians supporting emotional and 340 
psychological adjustment to amputation and prosthesis use should be mindful of the cognitive 341 
resources required and the potential for impaired cognitive functioning even in non-342 
dysvascular LLA. Lastly, how cognitive functioning impacts on the process of engagement in 343 
LLA rehabilitation itself  and subsequent rehabilitation outcomes 43 warrants examination.  344 
 345 
Study Limitations 346 
Differing completion rates for each of the neuropsychological assessments are a limitation of 347 
the present study. Assessments were undertaken during routine, busy rehabilitation 348 
programme schedules. Heterogeneous completion rates related to restrictions in participant 349 
scheduling and research availability, early discharge, declining to continue (often citing 350 
fatigue), and the time required for battery completion. Fractionation of assessment sessions 351 
due to fatigue and scheduling difficulties was previously reported in the only other study to 352 
report comparably comprehensive neuropsychological assessment in PwLLA 11.  353 
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The sample was slightly younger than all PwLLA attending rehabilitation at the 354 
recruitment site. Additionally, those who agreed to participate may have represented a more 355 
engaged and motivated patient subset. Indeed, VCI has been associated with elevated apathy 356 
44. Thus, the profile presented may underestimate cognitive impairment present in the LLA 357 
rehabilitation population. Differing aetiology group sizes reflected the preponderance of 358 
dysvascular LLA common in industrialized countries, but make it difficult to draw firm 359 
conclusions about the relationship between cognitive functioning and aetiology. Multi-site 360 
recruitment with matched cases may facilitate recruitment of those less likely to participate 361 
and aetiological comparisons. Further research could also recruit an appropriate control 362 
group, for example persons with acquired physical impairment but without VCI risk.  363 
Time of day (TOD) of testing may affect assessment p rformance across several 364 
neuropsychological variables of interest. Older age has been associated with lower 365 
performance in the afternoon compared to the morning, a d vice versa for younger age 45. 366 
While it was not possible to control for TOD effects within this study, this could be 367 
considered for future investigations.   368 
Previous examinations of working memory in LLA have employed similar digit span 369 
measures to assess working memory, with similar null fi dings 10,11,39. Digit forward and 370 
backward conditions incorporated in the WAIS-IV digit span test, measures of attention span 371 
and short term memory respectively 46, potentially confounded assessment. Alternatives 372 
should be considered, e.g. digit ordered conditions alone, or n-back tasks47.  373 
 374 
Conclusions  375 
Difficulties with cognitive functioning in LLA are many, varied, and not confined to vascular 376 
LLA. A true representation of cognitive functioning is best obtained with a comprehensive 377 
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neuropsychological assessment. Ultimately, increased knowledge about cognitive functioning 378 
in LLA could assist in supporting patients in rehabilitation and help them to optimise 379 
rehabilitation outcomes and overall quality of life.  380 
 381 
 382 
===== 383 
INCLUDE TABLE S1 AS ONLINE SUPPLEMENT 384 
=====  385 
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Table 1 
Demographic and Clinical Characteristics of the Sample 
Variable Level n 
% or M 
(SD) 
Range 
Age (years)   58.6 (15.3) 21 - 86 
Gender Male 65 74.7  
 Female 22 25.3  
Education (years)   12.5 (3.4) 4 – 23 
Marital status Married/cohabiting 44 51  
 Not married 43 49  
Amputation Below knee † 34 39.0  
 Above knee 41 47.1  
 Bilateral 12 13.8  
Aetiology Vascular  ‡ 69 79.3  
 Non-vascular  § 18 20.7  
Comorbidities 0 to 2 45 51.7  
 3+ 42 48.3  
Months since 
amputation 
  23.5 (73.7) 1 – 535 
Length of stay 
(weeks) 
  8.4 (4.1) 1 – 22 
Distress (HADS)  55 10.96 0 – 35 
NOTE. HADS = Hospital Anxiety and Distress Scale 22  
† Includes n=1 through-knee amputation  
‡ PVD, diabetes, osteomyelitis with comorbid diabetes  
§ Trauma, cancer, intravenous drug use 
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Table 2 
  
Neuropsychological Assessment Scores  
Domain Assessment Score Type 
Normative 
M (SD)  N M Median SD 
Min to 
Max t (df)  
Cohen's 
d Effect size 
Estimated 
premorbid 
intellectual ability 
WTAR 
Standard 
Score 
ST 100 (15) 50 96.2 99.5 19.35 50 to 123 
-1.388 
(49) -0.2 NS (small) 
Overall cognitive 
functioning MoCA Raw n/a 
† 58 22.9 23 3.99 9 to 30 n/a n/a n/a 
 
RBANS Total 
Index ST 100 (15) 72 84.96 86 16.9 
45 to 
121 
-7.605 
(72) * -0.9 Large 
Reasoning WAIS-IV Block Design SCL 10 (3) 60 8.2 8 3.18 1 to 17 
-4.388 
(59) * -0.57 Medium 
 
WAIS-IV 
Similarities SCL 10 (3) 60 8.13 8 2.9 1 to 15 
-4.982 
(59) * -0.64 Medium 
 
WAIS-IV 
Matrix 
Reasoning 
SCL 10 (3) 56 8.34 8 3.16 2 to 15 -3.928 (55) * -0.52 Medium 
Psychomotor 
speed 
D-KEFS TMT 
condition 5 
(motor speed) 
SCL 10 (3) 42 7.71 8 3.16 1 to 12 -4.693 (42) * -0.72 Medium 
Information 
processing 
D-KEFS 
CWIT 
condition 1 
(color naming) 
SCL 10 (3) 52 8.23 8 2.52 3 to 15 -5.068 (51) * -0.7 Large 
 
D-KEFS 
CWIT 
condition 2 
SCL 10 (3) 52 9.29 9.5 2.49 1 to 13 -2.059 (51) -0.29 NS (small) 
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(word reading) 
 
RBANS 
Coding Z 0 (1) 73 -1.77 -1.65 1.41 
-5.08 to 
+1.54 
-
10.699 
(72) * 
-1.25 Large 
 
WAIS-IV 
Symbol 
Search 
SCL 10 (3) 60 6.98 6.5 2.94 1 to 18 -7.940 (59) * -1.03 Large 
Attention RBANS Digit Span Z 0 (1) 76 0.07 0.18 1.12 
-2.47 to 
+2.29 
1.014 
(75) 0.12 NS (negligible) 
 
D-KEFS TMT 
condition 1 
(visual 
scanning) 
SCL 10 (3) 52 7.85 9 3.1 1 to 13 -5.007 (51) * -0.69 Medium 
 
D-KEFS TMT 
condition 2 
(number 
sequencing) 
SCL 10 (3) 54 7.17 8 3.88 1 to 14 -5.367 (53) * -0.73 Medium 
 
D-KEFS TMT 
condition 3 
(letter 
sequencing) 
SCL 10 (3) 53 6.81 8 3.93 1 to 14 -5.911 (52) * -0.81 Large 
 
TEA 
Telephone 
Search 
SCL 10 (3) 32 5.84 6 2.96 1 to 13 -7.934 (31) * -1.45 Large 
 
TEA 
Telephone 
Search With 
Counting 
SCL 10 (3) 32 9.13 8.5 4.14 1 to 19 -1.195 (31) -0.22 NS (small) 
Memory RBANS List Learning Z 0 (1) 76 -1.03 -0.96 1.2 
-3.88 to 
+1.38 
-6.940 
(75) * -0.8 Large 
 
CVLT-II SF 
Free Recall T-
Score (list) 
T 50 (10) 56 44.95 47 11.97 18 to 66 
-3.161 
(55) * -0.42 Medium 
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RBANS 
Immediate 
Story Memory 
Z 0 (1) 76 -0.41 -0.11 1.54 -4.65 to +1.76 
-2.070 
(75) -0.24 NS (small) 
 
WMS-IV 
Logical 
Memory I 
(story) 
SCL 10 (3) 59 8.07 8 4.15 1 to 16 -3.578 (58) * -0.47 Small 
 
CVLT-II SF 
Short Delay 
Recall (list) 
Z 0 (1) 53 -0.41 -0.5 1.37 -2.5 to 4.0 
-2.151 
(52) -0.3 NS (small) 
 
RBANS 
Delayed List 
Recall 
Z 0 (1) 76 -0.9 -0.83 1.19 -3.61 to +1.39 
-6.351 
(75) * -0.73 Medium 
 
CVLT-II SF 
Long Delay 
Recall (list) 
Z 0 (1) 52 -0.62 -0.5 1.04 -2.5 to 2.0 
-4.281 
(51) * -0.59 Medium 
 
RBANS 
Delayed Story 
Recall 
Z 0 (1) 76 -0.79 -0.5 1.32 -3.68 to +0.91 
-4.973 
(75) * -0.57 Medium 
 
WMS-IV 
Logical 
Memory II 
(story) 
SCL 10 (3) 59 7.68 8 4.07 1 to 16 -4.377 (58) * -0.57 Medium 
 
RBANS 
Figure Recall Z 0 (1) 77 -0.55 -0.59 1.14 
-3.48 to 
+1.97 
-3.867 
(76) * -0.44 Small 
 
CVLT-II SF 
Long Delay 
Cued Recall 
Z 0 (1) 52 -0.86 -0.5 1.06 -3.0 to 1.0 
-6.044 
(51) * -0.84 Large 
 
RBANS List 
Recognition Z 0 (1) 76 -2.18 -1.17 3.64 
-25.43 
to 
+0.67 
-5.051 
(75) * -0.58 Medium 
Language 
RBANS 
Picture 
Naming 
Z 0 (1) 76 -0.41 0.55 1.79 -7.4 to +1 
-2.044 
(75) -0.23 NS (small) 
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GNT raw 
score Raw n/a 
† 39 16.59 18 6.44 3 to 27 n/a   
Visuospatial 
cognition 
RBANS 
Figure Copy Z 0 (1) 77 -1.11 -0.85 2.05 
-8 to 
+1.29 
-4.745 
(76) * -0.54 Medium 
 
RBANS Line 
Orientation Z 0 (1) 77 -0.28 0.12 1.68 
-5.5 to 
+4.62 
-1.458 
(76) -0.17 Negligible 
 
VOSP 
Position 
Discrimination 
raw 
Raw n/a † 43 18.98 20 1.61 12 to 20 n/a n/a n/a 
Executive 
functions 
WAIS-IV Digit 
Span SCL 10 (3) 62 9.52 3.2 10 2 to 17 
-1.192 
(61) -0.15 Negligible 
 
D-KEFS 
CWIT 
condition 3 
(colour-word 
switching) 
SCL 10 (3) 50 7 8 3.95 1 to 13 -5.365 (49) * -0.76 Medium 
 
D-KEFS TMT 
condition 4 
(number-letter 
switching) 
SCL 10 (3) 53 5.81 6 3.99 1 to 13 -7.651 (52) * -1.05 Large 
 
RBANS 
Semantic 
Fluency 
Z 0 (1) 76 -0.91 -1 1.22 -3 to +2 -6.309 (75) * -0.72 Medium 
 
D-KEFS VFT 
condition 1 
(category 
fluency) 
SCL 10 (3) 57 8.42 8 3.74 3 to 17 -3.186 (56) * -0.42 Small 
 
D-KEFS VFT 
condition 2 
(letter fluency) 
SCL 10 (3) 57 8.12 8 3.73 2 to 19 -3.802 (56) *  -0.5 Medium 
 
BADS Zoo 
Map Raw n/a 
† 41 n/a 2 n/a 1 to 6 n/a n/a n/a 
 FrSBe self T 50 (10) 35 59.8 53 16.66 33 to 3.481 0.59 Medium 
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rated total 103 (34) * 
NOTE. BADS = Behavioural Assessment of the Dysexecutive Syndrome 38; CVLT-II SF = California Verbal Learning Test – II Short Form 39; 
D-KEFS = Delis-Kaplan Executive Function System (CWIT = Color-Word Interference Test; TMT = Trail Making Test; VFT = Verbal Fluency 
Test) 40; FrSBe = Frontal Systems Behavior Scale 21; GNT = Graded Naming Test 41; MoCA = Montreal Cognitive Assessment 42; RBANS = 
Repeatable Battery for the Assessment of Neuropsychological Status 43; TEA = Test of Everyday Attention 44; VOSP = Visual Object and 
Space Perception Battery 45; WAIS-IV = Wechsler Adult Intelligence Scales – IV 46; WMS-IV = Wechsler Memory Scales – IV 47; WTAR = 
Wechsler Test of Adult Reading 48  
* significant (p≤.003) after the Holm method of correction for multiple comparisons was employed  
† Raw scores: MoCA and GNT each have a possible raw scores ranging from 0 to 30. VOSP possible scores range from 0–20 (pass≥19, pass 
borderline=18, fail/impaired≤17/20). BADS zoo map possible scores range from 1 to 7 (pro-rated ordinal scale).  
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 1 
Table 3 2 
Neuropsychological Assessments: Proportions of Scores in the Borderline or Impaired  Ranges  
Domain Assessment N 
% 
borderline 
% 
impaired 
% 
impaired 
or border. 
p 
χ
2  
(df = 2) 
Aetiolo
gy N % impaired 
% 
borderline 
% impaired 
or border. 
Estimated 
premorbid 
intellectual 
ability 
WTAR 
Standard 
Score 
 
50 12 10 22 .001* 22.11 VAS 38 10.5 13.2 23.7 
      NV 12 8.3 8.3 16.7 
Overall 
cognitive 
functioning 
MoCA 
 
58 n/a n/a 52.6 † n/a n/a VAS 49 n/a n/a 61.2 
      NV 9 n/a n/a 11.1 
RBANS Total 
Index 
 
72 12.3 21.9 34.2 <.001* 158.47 VAS 58 24.1 13.8 37.9 
      NV 15 13.3 6.7 20.0 
Reasoning WAIS-IV 
Block Design 60 13.3 5 18.3 0.017 11.86 VAS 48 4.2 16.7 20.8 
       NV 12 8.3 0 8.3 
WAIS-IV 
Similarities 60 10 6.7 16.7 0.021 10.14 VAS 48 8.3 6.3 14.6 
       NV 12 0 25 25 
WAIS-IV 
Matrix 
Reasoning 
56 17.9 3.6 21.4 .003* 20.46 VAS 44 4.5 18.2 22.7 
       NV 12 0 16.7 16.7 
Psychomot
or speed 
D-KEFS TMT 
condition 5 
(motor speed) 
42 7.1 11.9 19 .001* 21.64 VAS 32 12.5 6.3 18.8 
       NV 10 10 10 20 
Information 
processing 
D-KEFS CWIT 
condition 1 
(color naming) 
52 7.7 3.8 11.5 0.438 1.76 VAS 40 2.5 10 12.5 
       NV 12 8.3 0 8.3 
D-KEFS CWIT 52 1.9 1.9 3.8 0.676 1.04 VAS 40 2.5 2.5 5 
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condition 2 
(word reading) 
       NV 12 0 0 0 
RBANS 
Coding 73 16.4 41.1 57.5 <.001* 597.05 VAS 58 46.6 19 65.5 
       NV 15 20 6.7 26.7 
WAIS-IV 
Symbol 
Search 
60 26.7 6.7 33.3 <.001* 67.34 VAS 49 6.1 30.6 36.7 
       NV 11 9.1 9.1 18.2 
Attention RBANS Digit 
Span 76 7.9 2.6 10.5 <.001* 1.53 VAS 60 3.3 5 8.3 
       NV 16 0 18.8 18.8 
D-KEFS TMT 
condition 1 
(visual 
scanning) 
52 9.6 9.6 19.2 .001* 18.13 VAS 42 11.9 11.9 23.8 
       NV 10 0 0 0 
D-KEFS TMT 
condition 2 
(number 
sequencing) 
54 5.6 24.1 29.6 <.001* 134.37 VAS 43 30.2 7 37.2 
       NV 11 0 0 0 
D-KEFS TMT 
condition 3 
(letter 
sequencing) 
53 5.7 30.2 35.8 <.001* 215.36 VAS 42 33.3 4.8 38.1 
       NV 11 18.2 9.1 27.3 
TEA 
Telephone 
Search 
32 17.2 24.1 41.4 <.001* 83.44 VAS 24 26.1 21.7 47.8 
       NV 8 25 0 25 
TEA 
Telephone 
Search With 
Counting 
32 10.3 3.4 13.8 0.393 2.11 VAS 24 4.3 13 17.3 
       NV 8 12.5 0 12.5 
Memory RBANS List 
Learning 76 7.9 27.6 35.5 <.001* 257.58 VAS 60 30 5 35 
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       NV 16 18.8 18.8 37.5 
CVLT-II SF 
Free Recall T-
Score (list) 
56 7.1 14.3 21.4 <.001* 44.03 VAS 44 15.9 9.1 25 
       NV 12 8.3 0 8.3 
RBANS 
Immediate 
Story Memory 
76 6.9 16.1 23 <.001* 106.79 VAS 60 23.3 5 28.3 
       NV 16 0 18.8 18.8 
WMS-IV 
Logical 
Memory I 
(story) 
59 16.9 16.9 33.9 <.001* 87.36 VAS 48 16.7 16.7 33.3 
       NV 11 18.2 18.2 36.4 
CVLT-II SF 
Short Delay 
Recall (list) 
53 11.3 15.1 26.4 <.001* 51.82 VAS 42 16.7 11.9 28.6 
       NV 11 9.1 9.1 18.2 
RBANS 
Delayed List 
Recall 
76 17.1 14.5 31.6 <.001* 86.34 VAS 60 15 18.3 33.3 
       NV 16 12.5 12.5 25 
CVLT-II SF 
Long Delay 
Recall (list) 
52 7.7 19.2 26.9 <.001* 80.17 VAS 42 19 7.1 26.2 
       NV 10 20 10 30 
RBANS 
Delayed Story 
Recall 
76 2.6 21.1 23.7 <.001* 141.07 VAS 60 25 3.3 28.3 
       NV 16 6.3 0 6.3 
WMS-IV 
Logical 
Memory II 
(story) 
59 5.1 28.8 33.9 <.001* 216.69 VAS 48 29.2 2.1 31.3 
       NV 11 27.3 18.2 45.5 
RBANS 
Figure Recall 77 13 9.1 22.1 <.001* 31.07 VAS 62 8.1 16.1 24.2 
       NV 15 13.3 0 13.3 
CVLT-II SF 52 11.5 25 36.5 <.001* 146.87 VAS 42 28.6 11.9 40.5 
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Long Delay 
Cued Recall 
       NV 10 10 10 20 
RBANS List 
Recognition 76 2.6 38.2 40.8 <.001* 506.99 VAS 60 40 3.3 43.3 
       NV 16 31.3 0 31.3 
Language RBANS 
Picture 
Naming 
76 1.1 15.8 17.1 <.001* 75.15 VAS 60 15 1.7 16.7 
       NV 16 18.8 0 18.8 
GNT raw 
score 39 n/a n/a n/a n/a n/a VAS 30 n/a n/a n/a 
       NV 9 n/a n/a n/a 
Visuospatia
l cognition 
RBANS 
Figure Copy 77 14.3 28.6 42.9 <.001* 295.75 VAS 62 33.9 16.1 50 
       NV 15 6.7 6.7 13.3 
RBANS Line 
Orientation 77 5.2 16.9 22.1 <.001* 87.17 VAS 61 21.3 6.6 27.9 
       NV 16 0 0 0 
VOSP 
Position 
Discrimination 
raw 
43 14 14 28 n/a n/a VAS 34 17.6 11.8 29.4 
       NV 9 0 22.2 22.2 
Executive 
functions 
WAIS-IV Digit 
Span 62 6.5 4.8 11.3 0.265 2.88 VAS 50 4 8 12 
       NV 12 8.3 0 8.3 
D-KEFS CWIT 
condition 3 
(colour-word 
switching) 
50 12 26 38 <.001* 154.07 VAS 39 30.8 15.4 46.2 
       NV 11 9.1 0 9.1 
D-KEFS TMT 
condition 4 
(number-letter 
switching) 
53 7.5 39.6 47.2 <.001* 384.98 VAS 42 42.9 7.1 50 
       NV 11 27.3 9.1 36.4 
RBANS 
Semantic 
76 18.4 22.4 40.8 <.001* 194.36 VAS 60 20 18.3 38.3 
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Fluency 
       NV 16 31.3 18.8 50 
D-KEFS VFT 
condition 1 
(category 
fluency) 
57 17.5 8.8 26.3 <.001* 33.25 VAS 45 8.9 20 28.9 
       NV 12 8.3 8.3 16.7 
D-KEFS VFT 
condition 2 
(letter fluency) 
57 8.8 10.5 19.3 <.001* 23.27 VAS 45 8.9 8.9 17.8 
       NV 12 16.7 8.3 25 
BADS Zoo 
Map 41 51.2 36.6 87.8
 † n/a n/a VAS 34 41.2 50.0 91.2 
       NV 7 14.3 57.1 71.4 
FrSBe self 
rated total 35 9.1 36.4 45.5 n/a n/a VAS 25 37.5 12.5 50 
       NV 10 33.3 0 33.3 
NOTE. VAS = vascular, NV = non-vascular. Impaired/borderline criteria: borderline (-1.99≤z≤-1.5; scale scores 4-5; ≤7th percentile approx.), impaired (z≤-2.0; scale 
scores 1-3; ≤2nd percentile), except; VOSP Position Discrimination (borderline: raw score 18/20; impaired: raw score ≤17/20), FrSBe (borderline: 60≤T≤64; 
impaired: T≥65). For the WTAR, the score terminology is ‘borderline’ or ‘extremely low’.  
* significant (p≤.003) after the Holm method of correction for multiple comparisons was employed  
† % scoring 23 or less for the MoCA brief cognitive screen; % in two lowest BADS categories, ‘borderline’ and ‘impaired’, of seven-point ordinal classification). 
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Cognitive Functioning: Comparison of Vascular (VAS) and Non-Vascular (NV) Aetiology Groups 
Domain Assessment Score Type 
Normative M 
(SD) Aetiology N M Median SD Min to Max 
Estimated 
premorbid 
intellectual 
ability 
WTAR Standard 
Score 
 
ST 100 (15) VAS 38 95.71 99.5 20.56 50 to 123 
  NV 12 97.75 100 15.61 64 to 120 
Overall cognitive 
functioning 
MoCA 
 
Raw n/a † VAS 49 22.41 23 3.99 9 to 30 
  NV 9 25.56 26 2.96 19 to 29 
RBANS Total Index 
 
ST 100 (15) VAS 58 83.5 84.5 17.43 45 to 121 
  NV 15 90.6 92 13.73 69 to 109 
Reasoning WAIS-IV Block 
Design SCL 10 (3) VAS 48 8.02 8 3.1 1 to 17 
   NV 12 8.92 9 3.53 2 to 16 
WAIS-IV Similarities SCL 10 (3) VAS 48 8.13 8 2.89 1 to 15 
   NV 12 8.17 8.5 3.07 4 to 13 
WAIS-IV Matrix 
Reasoning SCL 10 (3) VAS 44 8.11 8 2.98 2 to 15 
   NV 12 9.17 8.5 3.79 4 to 15 
Psychomotor 
speed 
D-KEFS TMT 
condition 5 (motor 
speed) 
SCL 10 (3) VAS 32 7.72 8 3.25 1 to 12 
   NV 10 7.7 9 3.02 1 to 11 
Information 
processing 
D-KEFS CWIT 
condition 1 (color 
naming) 
SCL 10 (3) VAS 40 8.1 8 2.45 3 to 15 
   NV 12 8.67 9 2.81 3 to 13 
D-KEFS CWIT 
condition 2 (word 
reading) 
SCL 10 (3) VAS 40 9.28 10 2.49 1 to 13 
   NV 12 9.33 8.5 2.61 6 to 13 
RBANS Coding Z 0 (1) VAS 58 -1.87 -1.83 1.44 -5.08 to 1.54 
   NV 15 -1.23 -0.97 1.05 -3.06 to 0.28 
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WAIS-IV Symbol 
Search SCL 10 (3) VAS 49 6.86 6 2.91 3 to 18 
   NV 11 7.55 7 3.17 1 to 12 
Attention RBANS Digit Span Z 0 (1) VAS 60 0.16 0.18 1.16 -2.47 to 2.76 
   NV 16 0.03 0.18 1.14 -1.88 to 1.46 
D-KEFS TMT 
condition 1 (visual 
scanning) 
SCL 10 (3) VAS 42 7.64 9 3.3 1 to 13 
   NV 10 8.7 8 2 6 to 12 
D-KEFS TMT 
condition 2 (number 
sequencing) 
SCL 10 (3) VAS 43 6.72 8 4.14 1 to 14 
   NV 11 8.91 9 1.87 6 to 12 
D-KEFS TMT 
condition 3 (letter 
sequencing) 
SCL 10 (3) VAS 42 6.6 8 3.99 1 to 14 
   NV 11 7.64 9 3.75 1 to 12 
TEA Telephone 
Search SCL 10 (3) VAS 24 5.38 5.5 2.67 1 to 13 
   NV 8 7.25 7.5 3.54 2 to 12 
TEA Telephone 
Search With 
Counting 
SCL 10 (3) VAS 24 9 8 4.36 4 to 15 
   NV 8 9.5 9 3.63 3 to 15 
Memory RBANS List 
Learning Z 0 (1) VAS 60 -1.01 -0.96 1.24 -3.88 to 1.38 
   NV 16 -0.8 -0.79 1.14 -2.87 to 0.77 
CVLT-II SF Free 
Recall T-Score (list) T 50 (10) VAS 44 44.02 46 12.12 18 to 66 
   NV 12 48.33 52 11.19 20 to 60 
RBANS Immediate 
Story Memory Z 0 (1) VAS 60 -0.46 -0.11 1.59 -4.65 to 1.76 
   NV 16 0.025 0.2 1.17 -1.84 to 1.49 
WMS-IV Logical 
Memory I (story) SCL 10 (3) VAS 48 8.02 8 3.91 1 to 15 
    NV 11 8.27 8 5.27 1 to 16 
CVLT-II SF Short 
Delay Recall (list) Z 0 (1) VAS 42 -0.46 -0.5 1.38 -2.5 to 4 
   NV 11 -0.18 -0.5 1.38 -2.5 to 2 
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RBANS Delayed 
List Recall Z 0 (1) VAS 60 -0.89 -0.87 1.13 -2.86 to 0.95 
   NV 16 -0.73 -0.837 1.37 -3.61 to 1.39 
CVLT-II SF Long 
Delay Recall (list) b Z 0 (1) VAS 42 -0.58 -0.5 1.06 -2.5 to 2 
   NV 10 -0.75 -0.5 0.98 -2.5 to 0.5 
RBANS Delayed 
Story Recall Z 0 (1) VAS 60 -0.85 -0.5 1.41 -3.68 to 0.91 
   NV 16 -0.35 -0.5 0.78 -2.27 to 0.9 
WMS-IV Logical 
Memory II (story) SCL 10 (3) VAS 48 7.71 8 3.89 1 to 14 
   NV 11 7.55 6 5.01 1 to 16 
RBANS Figure 
Recall Z 0 (1) VAS 62 -0.6 -0.7 1.07 -2.58 to 1.97 
   NV 15 -0.16 -0.03 1.53 -3.48 to 1.67 
CVLT-II SF Long 
Delay Cued Recall Z 0 (1) VAS 42 -0.94 -0.75 1.07 -3 to 1 
   NV 10 -0.65 -0.5 1 -3 to 0.5 
RBANS List 
Recognition Z 0 (1) VAS 60 -1.91 -1.17 2.36 -9.5 to 0.67 
   NV 16 -2.66 0.16 6.44 -25.43 to 0.5 
Language RBANS Picture 
Naming Z 0 (1) VAS 60 -0.46 0.57 1.88 -7.4 to 0.9 
   NV 16 -0.21 0.55 1.13 -2.29 to 1 
GNT raw score Raw n/a † VAS 30 16.63 17.5 6.61 3 to 27 
   NV 9 16.44 18 6.23 3 to 24 
Visuospatial 
cognition 
RBANS Figure 
Copy Z 0 (1) VAS 62 -1.35 -1.4 2.08 -8 to 1.29 
   NV 15 -0.13 0.5 1.64 -5.21 to 1.29 
RBANS Line 
Orientation Z 0 (1) VAS 61 -0.54 -0.207 1.75 -5.5 to 4.62 
   NV 16 0.72 0.73 0.866 -0.85 to 3.2 
VOSP Position 
Discrimination raw Raw n/a
 † VAS 34 18.82 19.5 1.73 12 to 20 
   NV 9 19.56 20 0.88 18 to 20 
Executive 
functions 
WAIS-IV Digit Span SCL 10 (3) VAS 50 9.38 9.5 3.17 2 to 17 
   NV 12 10.08 11 3.4 3 to 15 
D-KEFS CWIT 
condition 3 (colour-
SCL 10 (3) VAS 39 6.31 6 3.9 1 to 13 
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word switching) 
   NV 11 9.45 10 3.21 1 to 13 
D-KEFS TMT 
condition 4 
(number-letter 
switching) 
SCL 10 (3) VAS 42 5.38 5 3.83 1 to 13 
   NV 11 7.45 9 4.34 1 to 13 
RBANS Semantic 
Fluency Z 0 (1) VAS 60 -0.84 -0.87 1.22 -3 to 2 
   NV 16 -1.38 -1.37 1.6 -5.8 to 0.38 
D-KEFS VFT 
condition 1 
(category fluency) 
SCL 10 (3) VAS 45 8.38 8 3.94 3 to 17 
   NV 12 8.58 8.5 3.03 3 to 13 
D-KEFS VFT 
condition 2 (letter 
fluency) 
SCL 10 (3) VAS 45 8.44 8 3.84 2 to 19 
   NV 12 6.92 7.5 3.15 2 to 12 
BADS Zoo Map Raw n/a † VAS 34 n/a 2 n/a 1 to 6 
   NV 7 n/a 2 n/a 1 to 6 
FrSBe self rated 
total T 50 (10) VAS 25 61.04 59 17.27 29 to 99 
   NV 10 56.7 53.5 15.42 35 to 82 
† Raw scores: MoCA and GNT each have a possible raw scores ranging from 0 to 30. VOSP possible scores range from 0–20 (pass≥19, pass borderline=18, 
fail/impaired≤17/20). BADS zoo map possible scores range from 1 to 7 (pro-rated ordinal scale). 
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